XML 58 R45.htm IDEA: XBRL DOCUMENT v3.22.1
SELECTED STATEMENTS OF INCOME DATA (Tables)
 12 Months Ended
Dec. 31, 2021
Income Statement Related Disclosures [Abstract]  
Schedule of Research and Development Costs, Net Research and development, net:
Year Ended December 31,
202120202019
Total costs$319,083 $261,105 $232,118 
Less - grants and participations(2,118)(2,347)(2,556)
Less - capitalization of software development costs(45,778)(40,576)(35,844)
$271,187 $218,182 $193,718 
Schedule of Financial Income (Expenses) and Other, Net Financial expenses and other, net:
Year Ended December 31,
202120202019
Financial income:
Interest and amortization/accretion of premium/discount on marketable securities, net$13,751 $17,596 $16,678 
Interest200 1,543 3,855 
13,951 19,139 20,533 
Financial expenses:
Interest(10,061)(7,770)(11,683)
Loss in respect of debt extinguishment(13,969)— — 
Debt issuance costs amortization(610)(3,650)(2,083)
Exchangeable Senior Notes amortization of discount(5,708)(9,648)(7,153)
Exchange rates differences(4,131)(41)(1,832)
Other(2,958)(2,731)(2,186)
(37,437)(23,840)(24,937)
Other (expenses) Income, net196 (158)(40)
$(23,290)$(4,859)$(4,444)
Schedule of Computation of Net Earnings Per Share
The following table sets forth the computation of basic and diluted net earnings per share:
1.Numerator:
Year Ended December 31,
202120202019
Net income to ordinary shareholders$199,223 $196,346 $185,904 
2.Denominator (in thousands):
Year Ended December 31,
202120202019
Denominator for basic net earnings per share:
Weighted average number of shares (thousand)63,189 62,710 62,120 
Effect of dilutive securities:
Add - employee stock options and RSU1,605 1,611 1,682 
Warrants issued in the exchangeable notes transaction2,102 1,635 859 
Denominator for diluted net earnings per share - adjusted weighted average shares (thousand)66,896 65,956 64,661